<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The case of a 11-year-old boy under <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy for a familial <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome (SAAPF), who underwent surgery for a cerebrovascular malformation responsible for an intracerebral haematoma, is reported </plain></SENT>
<SENT sid="1" pm="."><plain>Antivitamins K (AVK) were changed for unfractioned <z:chebi fb="5" ids="28304">heparin</z:chebi> (HNF), three days before </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="5" ids="28304">Heparin</z:chebi> was discontinued two hours prior to surgery to obtain a <z:mpath ids='MPATH_458'>normal</z:mpath> peroperative coagulation </plain></SENT>
<SENT sid="3" pm="."><plain>A vascular dural <z:mpath ids='MPATH_70'>fistula</z:mpath> was removed without any haemostatic problem </plain></SENT>
<SENT sid="4" pm="."><plain>The neurological status rapidly returned to <z:mpath ids='MPATH_458'>normal</z:mpath> and tomodensitometry at day 1 showed a <z:mpath ids='MPATH_458'>normal</z:mpath> intracranial status </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="5" ids="28304">Heparin</z:chebi> was readministered at h 16 </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0001873'>Thrombocytopenia</z:hpo> occurred at day 4 of <z:chebi fb="5" ids="28304">heparin</z:chebi> treatment </plain></SENT>
<SENT sid="7" pm="."><plain>The change for a <z:hpo ids='HP_0004325'>low weight</z:hpo> molecular heparinoid, danaparoid (Orgaran), normalized the platelet count </plain></SENT>
<SENT sid="8" pm="."><plain>The platelets aggregation tests were negative during <z:mp ids='MP_0003179'>thrombopenia</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>However, the test for antibodies against the <z:chebi fb="0" ids="30203">PF4</z:chebi>-<z:chebi fb="5" ids="28304">heparin</z:chebi> complex with the Elisa technique, was in favour of a <z:hpo ids='HP_0011874'>heparin induced thrombocytopenia</z:hpo> (TIH) </plain></SENT>
<SENT sid="10" pm="."><plain>In spite of its anecdotic occurrence due to cumulative thrombotic risks from the association of <z:e sem="disease" ids="C0021053" disease_type="Disease or Syndrome" abbrv="">immunologic disorders</z:e> (TIH and SAAPF), this case report underlines the value but also the risks of <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy in neurosurgery, when patients are at high risk for <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
</text></document>